GlassScriptPhysician profile
Jonathan Wesley Linder
NPI 1598326597
$739.24
in general payments reported to CMS, 2019-2025
12 companies · $231 in 2025
The $231 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $51.33 · 2022: $190 · 2023: $222 · 2024: $45.04 · 2025: $231.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $498.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $498.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $139.97 | 2022-2025 | Azstarys |
| Cranial Technologies, INC | $104.92 | 2022-2025 | Doc Band |
| Merck Sharp & Dohme LLC | $82.46 | 2021-2025 | Gardasil 9, Vaxneuvance, Rotateq |
| Sanofi Pasteur INC. | $80.97 | 2023-2025 | |
| Sobi, INC | $74.13 | 2022-2023 | |
| Takeda Pharmaceuticals U.S.A., INC. | $72.62 | 2021-2022 | |
| Supernus Pharmaceuticals, INC. | $44.48 | 2025 | Qelbree |
| Glaxosmithkline, LLC. | $41.41 | 2022 | |
| Ironshore Pharmaceuticals INC. | $37.00 | 2022-2024 | |
| Pfizer INC. | $28.19 | 2022-2025 | |
| Azurity Pharmaceuticals, INC. | $17.70 | 2025 | Alvesco |
| Collegium Pharmaceutical, INC. | $15.39 | 2025 | Jornay Pm |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Linder listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.